Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

Dr Hilary says it is vital that you visit a medical professional to get checked out if you are showing symptoms ...

A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory ...

The recommendation for Enflonsia is indicated for respiratory syncytial virus prevention in infants under eight months of age, expanding protection options ahead of the 2025–2026 season.

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F.

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...